Company Analysis

Pyxis Oncology, Inc. (PYXS)

Nasdaq: PYXS · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2019
Grade4.6
◀ Past 5.6● Present 3.3▶ Future 5.1
4 est.

Who runs Pyxis Oncology, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Civik Thomas
CEO & Chairman of the Board. First filing Oct 2021, latest Sep 8, 2026, 1 filing in all.
Officers reporting now
2
of 9 people with a filing in the last fifteen months
Directors reporting now
7
17 people on the record since 2021
Officerssales are open-market, Nov 6, 2025 to Nov 6, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Civik ThomasCEO & Chairman of the BoardOct 2021Sep 8, 2026none
Wadhane JitendraPrin Fin & Acct OfficerAug 2022Mar 25, 2026none
Directorssales are open-market, Nov 6, 2025 to Nov 6, 2026
NameRoleFirst filingLatest filingSales, 12 months
Humphrey RacheldirectorAug 2022Nov 6, 2026none
Dupont JakobdirectorAug 2023Aug 20, 20261 · $100,000
Cline Darren SdirectorOct 2021Mar 25, 2026none
Flavin John LdirectorOct 2021Mar 25, 2026none
Lewis-Hall Freda CdirectorOct 2021Mar 25, 2026none
Metzger Michael AdirectorJun 2024Mar 25, 2026none
Palani SanthoshdirectorMar 2024Mar 25, 2026none
Owners of more than 10% of a classsales are open-market, Nov 6, 2025 to Nov 6, 2026
NameRoleFirst filingLatest filingSales, 12 months
Gordon Craig D10% ownerJul 2026Oct 9, 2026none
Gordonmd Global Investments LP10% ownerJul 2026Oct 9, 2026none
Gordonmd Long Biased Gp LLC10% ownerJul 2026Oct 9, 2026none
Gordonmd Long Biased Master Fund LP10% ownerJul 2026Oct 9, 2026none
Earlier names on the record16, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton PYXS · research, not advice